Santo Therapeutics
PrivateLast Round
Angel
Sep 28, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Santo Therapeutics operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was an Angel round in September 2025.
Santo Therapeutics is a biotechnology company that develops next-generation lentiviral vector gene therapies for cancer and rare genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Santo Therapeutics Comparables
Compare Santo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Abintus Bio | 81% | |
| NF2 Therapeutics, Inc. | 77% | |
| Vyriad | 75% |
For institutional investors. Book with your work email.
Santo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Sep 28, 2025 | ||||
| Angel | Dec 29, 2023 |
For institutional investors. Book with your work email.
Santo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Triwise Capital | Angel |
| Transfar Capital | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 33% MoM.
For institutional investors. Book with your work email.
Santo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Santo Therapeutics's valuation, stock price, and market status.
Is Santo Therapeutics a public or private company?
Santo Therapeutics is a private company.
What is the current stock price of Santo Therapeutics?
Santo Therapeutics is a private company, so its shares have no public market price. Caplight tracks Santo Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Santo Therapeutics worth (valuation)?
Valuation information for Santo Therapeutics is not publicly available.
Can I buy Santo Therapeutics stock?
Santo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Santo Therapeutics's last funding round?
Santo Therapeutics's most recent funding round was Angel on September 28, 2025.
Who are the main investors in Santo Therapeutics?
Key investors in Santo Therapeutics include Transfar Capital.
Will Santo Therapeutics IPO soon?
No public IPO plans have been announced for Santo Therapeutics.
How can I track Santo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Santo Therapeutics's shares on secondary markets.